Personalized Peptides for Neoantigen Vaccines

Personalized Peptides for Neoantigen Vaccines
Product Description

Robust timelines, extensive knowledge and experience and redundant set-up in our all-in-one facility make us the reliable personalized peptide supplier - The usage of synthetically produced tumor-specific neoantigen peptides in cancer vaccines is a rapidly growing and highly promising therapeutic field in cancer treatment. Preparing neoantigen peptides demands the highest level of care and reliability in terms of tailoring to the patient’s specifications and timely delivery for their care. Owing to our thorough expertise in peptide chemistry and our role as critical partner in multiple clinical trial projects, Pepscan knows what it takes to be a world-class partner in this field.

Pepscan

  • NL
  • 2021
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator

Pepscan

  • NL
  • 2021
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator

More Products from Pepscan (4)

  • Peptide lead optimization

    Product Peptide lead optimization

    Increasing peptide drug potency and improving pharmacokinetic properties through lead optimization of linear and CLIPS-constrained peptides -
    We have developed a diverse library of enhanced CLIPS molecules, which after incorporation can lead to improved peptide conformation as well as better ...
  • Peptide discovery

    Product Peptide discovery

    Unique service for de novo discovery of the best peptide binders for your target protein of interest - Pepscan offers proprietary peptide technologies, peptide chemistry expertise and a strong track record in contract research and R&D collaborations to scientists looking for the best constrained pe...
  • Lipidated peptides

    Product Lipidated peptides

    Combining smart peptide science and flexible manufacturing capabilities conform GMP - A therapeutic peptide’s pharmacokinetic properties can be improved by linking it to a lipid tail. This form of post-synthesis modification results in a longer life time of the peptide, which increases the chance of ...
  • Peptides for nuclear medicine - Theranostics - Readiopharmaceuticals

    Product Peptides for nuclear medicine - Theranostics - Readiopharmaceuticals

    Radiopharmaceuticals that combine smart peptide technologies with flexible GMP conform manufacturing capabilities - Pepscan employs some of the industry’s finest chemists to design the radiolabeled peptides fit for your purpose. Pepscan has a proven track record in the field of radiopharmaceuticals and ...

Pepscan resources (2)

  • News Pepscan supports Ardigen ImmuMap research collaboration with its neoantigen peptide synthesis capabilities

    Pepscan will use its 25 years of experience in peptide synthesis to deliver large quantities of custom neoantigen peptides to the research collaboration between Ardigen and Immumap. ImmuMap will perform the experimental validation of T-cell receptors towards newly identified neoantigens of solid-tumor patients using Pepscan’s neoantigen peptides. The outcome will accelerate Ardigen’s TCR-based therapy discovery and development using artificial intelligence.
  • Brochure Pepscan - Enabling life-improving breakthroughs by mastering peptides

    Combining smart peptide science and flexible manufacturing capabilities conform GMP - Over the last few years, we have made tremendous efforts and investments in building our GMP capabilities at our Dutch all-in-one facility. Starting from GMP production of neoantigen vaccines at microgram scale, we have rapidly expanded to GMP production at gram scale, building on our 25-year track record in peptides. This has also increased our flexibility so we can deliver batches based on our customers’ timelines.